ANPAC BIO-MED SP.ADS/20 A Depository Receipt · US03635R2067 · ANPC (LSSI) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ANPAC BIO-MED SP.ADS/20 A
No Price
Company Profile for ANPAC BIO-MED SP.ADS/20 A Depository Receipt
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Company Data
Name ANPAC BIO-MED SP.ADS/20 A
Company AnPac Bio-Medical Science Co., Ltd.
Symbol ANPC
Website
https://www.anpacbio.com
Primary Exchange 
Lang & Schwarz
Lang & Schwarz
ISIN US03635R2067
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Chris Chang Yu
Market Capitalization 27 Mio
Country China
Currency EUR
Employees 0,1 T
Address 801 Bixing Street, 323006 Lishui
IPO Date 2020-01-30
Stock Splits
| Date | Split |
|---|---|
| 04.11.2022 | 1:20 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 0UC0.F |
| NASDAQ | ANPC |
More Shares
Investors who hold ANPAC BIO-MED SP.ADS/20 A also have the following shares in their portfolio:
